Emilia Roy-Vallejo

8PUBLICATIONS
39CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Haematological tumoursAutoimmunityDevelopmental genetics (incl. sex determination)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 28, 2024
Prognostic Value of D-dimer to Lymphocyte Ratio (DLR) in Hospitalized Coronavirus Disease 2019 (COVID-19) Patients: A Validation Study in a National Cohort.

Crhistian-Mario Oblitas, Pablo Demelo-Rodríguez, Luis-Antonio Alvarez-Sala-Walther

|Dec 30, 2022
Dasatinib-induced spleen contraction leads to transient lymphocytosis.

Ana Marcos-Jiménez, Daniela Claudino Carvoeiro, Nora Ruef

|Nov 11, 2022
Galectin-1: A Potential Biomarker Differentiating between Early Rheumatoid Arthritis and Spondyloarthritis.

Ana Triguero-Martínez, Emilia Roy-Vallejo, Eva Gloria Tomero

|Jul 09, 2022
Genetic LGALS1 Variants Are Associated with Heterogeneity in Galectin-1 Serum Levels in Patients with Early Arthritis.

Ana Triguero-Martínez, Emilia Roy-Vallejo, Nuria Montes

|Mar 25, 2022
Advances in the Treatment of Giant Cell Arteritis.

Santos Castañeda, Diana Prieto-Peña, Esther F Vicente-Rabaneda

|Jul 02, 2021
Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Withdrawal Is Associated with Higher Mortality in Hospitalized Patients with COVID-19.

Emilia Roy-Vallejo, Aquilino Sánchez Purificación, José David Torres Peña

Pageof 2